CSBR
Champions Oncology Inc
NASDAQ: CSBR · HEALTHCARE · BIOTECHNOLOGY
$5.85
-1.01% today
Updated 2026-04-29
Market cap
$81.45M
P/E ratio
—
P/S ratio
1.41x
EPS (TTM)
$-0.18
Dividend yield
—
52W range
$6 – $10
Volume
0.0M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D3.5
Quality
D2.0
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-1.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$12.00
+105.12%
12-Month target
—
—
Intrinsic (DCF)
$12.95
Margin of safety
+54.44%
Price chart
X-Ray snapshot
Strengths
+ 54.44% below intrinsic value
Risks
- Altman Z -1.20 — distress zone
- Thin margins at -4.04%
- Negative free cash flow $-1.38M
- Revenue declining -2.80% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $49.11M | $53.87M | $50.16M | $56.94M | $57.95M |
| Net income | $548000.00 | $-5.33M | $-7.28M | $4.70M | $-279000.00 |
| EPS | — | — | — | — | $-0.18 |
| Free cash flow | $4.11M | $1.08M | $-6.97M | $7.00M | $-1.38M |
| Profit margin | 1.12% | -9.90% | -14.51% | 8.26% | -4.04% |
Peer comparison
Smart narrative
Champions Oncology Inc trades at $5.85. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -1.20, it sits in the distress. TTM revenue stands at $57.95M. with profit margins at -4.04%. Our DCF model estimates intrinsic value at $12.95.
Frequently asked questions
What is Champions Oncology Inc's stock price?
Champions Oncology Inc (CSBR) trades at $5.85.
Is Champions Oncology Inc overvalued?
Smart Value Score 19/100 (Grade F, Strong Sell). DCF value $12.95.
What is the price target of Champions Oncology Inc (CSBR)?
The analyst target price is $12.00, representing +105.1% upside from the current price of $5.85.
What is the intrinsic value of Champions Oncology Inc (CSBR)?
Based on our DCF model, intrinsic value is $12.95, a +54.4% margin of safety versus $5.85.
What is Champions Oncology Inc's revenue?
TTM revenue is $57.95M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-1.20 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.41x
ROE-47.60%
Beta0.40
50D MA$5.93
200D MA$6.58
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—